Location History:
- München, DE (2004 - 2007)
- Munich, DE (1996 - 2012)
- Münich, DE (2002 - 2012)
Company Filing History:
6 out of 40 
1 out of 1 
1 out of 3 Years Active: 1996-2012
Title: Innovations of Volker Erfle: Pioneering Recombinant MVA Virus Technologies
Introduction
Volker Erfle, an esteemed inventor based in Munich, Germany, has made significant contributions to the field of biotechnology with a remarkable portfolio of 12 patents. His work primarily focuses on recombinant viruses that hold immense potential for medical applications, including vaccines and gene therapy.
Latest Patents
Among his latest innovations is a patent for the recombinant MVA virus, which relates to modified vaccinia viruses derived from the modified vaccinia virus Ankara (MVA). This invention encompasses recombinant viruses capable of expressing foreign genes, strategically inserted at naturally occurring deletions in the MVA genome. The applications of this technology include the production of polypeptides, such as antigens or therapeutic agents, and the development of viral vectors for gene therapy. Furthermore, these recombinant MVA viruses encoding antigens present promising avenues as vaccines, reflecting a significant advancement in vaccine technology.
Career Highlights
Volker Erfle's career includes notable affiliations with the GSF Forschungszentrum für Umwelt und Gesundheit (now part of the Helmholtz Zentrum München), where he has contributed to various research projects that leverage his expertise in virology and molecular biology.
Collaborations
Throughout his career, Erfle has collaborated with prominent researchers, including Gerd Sutter and Marion Ohlmann, who have played integral roles in the advancement of the field. These collaborative efforts have fostered innovation and facilitated the exploration of new therapeutic methods.
Conclusion
Volker Erfle stands out as a key figure in the biotechnology sector, especially with his groundbreaking work on recombinant MVA viruses. His inventions not only enhance our understanding of viral mechanisms but also pave the way for developing effective vaccines and gene therapies, marking him as a vital contributor to modern medical science.